Live Breaking News & Updates on Myelin Oligodendrocyte Glycoprotein

Stay updated with breaking news from Myelin oligodendrocyte glycoprotein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Imcyse Announces Completion of Enrollment in Phase 1 Clinical Trial of ImotopeTM IMCY-0141 for the Treatment of Multiple Sclerosis

Imcyse Announces Completion of Enrollment in Phase 1 Clinical Trial of ImotopeTM IMCY-0141 for the Treatment of Multiple Sclerosis
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Region Flamande , Baden Wüberg , Anne Hennecke Lydia Robinson Garcia , Denis Bedoret , Andrew Mackie , Jean Van Rampelbergh , Chuck Padala , Data Monitoring Committee , Catholic University Of Leuven , Mc Services , Van Rampelbergh , Independent Data Monitoring Committee , Myelin Oligodendrocyte Glycoprotein , Catholic University , Media Inquiries ,

Possible biomarker of MS-like autoimmune disease discovered

Possible biomarker of MS-like autoimmune disease discovered
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Ribeiro Gomes , Beatriz Ayroza Galv , University Of Basel , University Hospital Basel , University Hospital Of Basel , Clinical Characterization , Patients Seropositive , Myelin Oligodendrocyte Glycoprotein , University Hospital , Ana Beatriz Ayroza Galv ,

Sangamo Therapeutics Inc (SGMO) Q1 2021 Earnings Call Transcript


Operator
Good day, and thank you for standing by. Welcome to the Sangamo First Quarter 2021 Teleconference Call. [Operator Instructions].
I would now like to hand the conference over to your speaker today, Aron Feingold, Head of Corporate Communications. Please go ahead.
Aron Feingold
Head of Corporate Communications
Good afternoon, and thank you for joining us today. With me this afternoon on this call are several members of the Sangamo executive leadership team, including Sandy Macrae, Chief Executive Officer; Mark McClung, Chief Business Officer; Jason Fontenot, Chief Scientific Officer; Rob Schott, Head of Development; and Bettina Cockroft, Chief Medical Officer. Slides from our corporate presentation can be found on our website, sangamo.com, under the Investors and Media section on the Events and Presentations page. ....

United States , Kenny Chan , Bettina Cockroft , Andreas Argyrides Wedbush , Gena Wang , Kenny Chan Jefferies , Aaron Feingold , Debjit Chattopadhyay , Rob Schott , Yanan Zhu , Swapnil Malekar Barclays , Geoff Meacham , Mark Mcclung , Sandy Macrae , America Merrill Lynch , Ben Burnett , Peter Marks , Andreas Argyrides , Aaron Welch Guggenheim , Maury Raycroft , Lisa Walter , Baral Cowen , Jason Fontenot , Aron Feingold Head Of Corporate Communications , Aspen Mori Bank , Sangamo Therapeutics Inc ,